Current issues with acetaminophen hepatotoxicity—A clinically relevant model to test the efficacy of natural products
Top Cited Papers
- 4 February 2011
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 88 (17-18), 737-745
- https://doi.org/10.1016/j.lfs.2011.01.025
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- HepaRG Cells: A Human Model to Study Mechanisms of Acetaminophen Hepatotoxicity ΔσHepatology, 2010
- No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicityHepatology, 2010
- CXC receptor‐2 knockout genotype increases X‐linked inhibitor of apoptosis protein and protects mice from acetaminophen hepatotoxicity†Hepatology, 2010
- Role of caspase-1 and interleukin-1β in acetaminophen-induced hepatic inflammation and liver injuryToxicology and Applied Pharmacology, 2010
- c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicityToxicology and Applied Pharmacology, 2010
- Novel Mechanisms of Protection Against Acetaminophen Hepatotoxicity in Mice by Glutathione and N-AcetylcysteineHepatology, 2009
- The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in miceToxicology Letters, 2009
- Mechanism of protection by metallothionein against acetaminophen hepatotoxicityToxicology and Applied Pharmacology, 2009
- Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of ForcesChemical Research in Toxicology, 2009
- Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxideHepatology, 2008